2m 2m 2m 2m 2m 2m 2m
RANI THERAP-A (RANI)
NASDAQ
$0.80-$0.009 (-1.09%)
Price as of Oct 02, 2026 7:30 PM EDT- $91.8MMarket Cap
- 60.55%1-Year Change
- BiotechnologyIndustry
RANI THERAP-A (RANI)
$0.80-$0.009 (-1.09%)
RANI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.81 | ||
Change | +$0.004 (+0.57%) | ||
Open | $0.81 | ||
High | $0.83 | ||
Low | $0.80 | ||
Previous Close | $0.80 | ||
Volume | 418,523 | ||
30-Day Average Volume | 557,291 | ||
1-Week Change | 6.21% | ||
1-Month Change | -7.98% | ||
1-Year Change | 57.52% | ||
3-Year Change | -63.43% | ||
5-Year Change | -95.61% | ||
Fundamentals | |||
Shares Outstanding | 115.4M | ||
Total Assets | $60.8M | ||
Market Cap | $91.8M | ||
Enterprise Value | $87.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$7.4M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$7.4M | ||
EBITDA | -$7.2M | ||
Net Working Capital | $45.9M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 2 | ||
P/E | -20 | ||
PEG | N/A | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue